Oncolytics Biotech Inc. (ONCY) Stock: Seeing Gains In Today’s Session


Oncolytics Biotech Inc. (ONCY) is working its way for to the top in the market in today’s trading session. The company, focused in the biotechnology sector, is presently priced at $1.80 after climbing 1.88% so far in today’s session. In terms of biotech stocks, there are several aspects that have the potential to generate price movement in the market. One of the most common is news. Here are the recent headlines surrounding ONCY:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-08-19 07:00AM Oncolytics Biotech (R) Announces 2018 Year-End Results and Operational Highlights
Mar-01-19 07:00AM Oncolytics Biotech(R) to Host Conference Call to Discuss Year End Financial Results and Operational Highlights
Feb-28-19 04:31PM Penny Stocks to Buy Using Technical Analysis for March 2019
Feb-27-19 04:55PM Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR
Feb-11-19 07:00AM Oncolytics Biotech(R) Announces Spanish Regulatory Approval of AWARE-1 Window of Opportunity Study in Breast Cancer

However, when making a decision to invest, prospective investors should focus on far more than news, especially in the highly speculative biotech sector. Here’s what’s going on with Oncolytics Biotech Inc..

Recent Trends From ONCY

Although a move up on a single session, like the gain that we’re seeing from Oncolytics Biotech Inc. may cause excitement in some investors, a single session gain alone should not be the basis of a decision to, or not to, buy a company’s stock. It’s always important to take a look at trends just a single trading day. In the case of ONCY, below are the movements that investors have experienced:

  • Past 7 Days – Over the past 5 trading sessions, ONCY has produced a change in price that amounts to -11.17%.
  • Monthly – The monthly returns from Oncolytics Biotech Inc. has been -12.92%.
  • Quarterly – Throughout the last 3 months, the company has generated a return that comes to -23.14%
  • Past 6 Months – Throughout the previous 6 months, we have seen a change of -56.88% from the stock.
  • Year To Date – Since the the first trading session of this year ONCY has resulted in a return of -2.33%.
  • Annually – Finally, over the last full year, we have seen movement of -69.49% out of ONCY. In this period, the stock has sold at a high price of -78.04% and a low price of 9.94%.

Ratios To Pay Attention To

Digging into a few ratios associated with a company can provide prospective investors a look of how dangerous and/or rewarding a pick may be. Below are a few of the most important ratios to think about when looking at ONCY.

Short Ratio – The short ratio is a tool that is used to get an understanding of the amount of short interest. The higher this ratio, the more investors believe that the stock is going to go down. Throughout the sector, biotechnology stocks can carry a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the sector. Nonetheless, when it comes to Oncolytics Biotech Inc., it’s short ratio amounts to 0.67.

Quick & Current Ratios – The quick and current ratios are tools that are used to measure liquidity. Basically, they measure whether or not a company can cover its debts when they mature using quick assets or current assets. In the biotech space, many companies are heavily reliant on the continuation of support from investors, these ratios can look upsetting. However, several good picks in the biotechnology sector do have positive current and quick ratios. When it comes to ONCY, the quick and current ratios add up to 5.10 and 5.10 respectively.  

Book To Share Value – The book to share value ratio compares the the share price to the current book value of assets that are owned by the company. In this case, that ratio is 0.27.

Cash To Share Value – Finally, the cash to share value comparison compares the total cash on hand to the price of the company’s stock. Several early stage biotechnology companies have a hard time keeping cash on hand. So, if you’re considering an investment in a biotechnology stock, this is a very important ratio to look into. In the case of ONCY, the cash to share value works out to 0.55.

How Analysts Feel About Oncolytics Biotech Inc.

While it’s rarely a smart idea to blindly follow the opinions of analysts, it is a smart idea to consider their analysis when validating your own opinions before making investment decisions in the biotech space. Below you’ll find|Here are} the recent moves that we have seen from analysts when it comes to ONCY.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Is Big Money Interested in Oncolytics Biotech Inc.?

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in ONCY, here’s what we’re seeing:

  • Institutional Investors – Currently, institutions own 2.50% of ONCY. However, it’s important to mention that institutional ownership has moved in the amount of 0 throughout the past 3 months.
  • Insider Holdings – As far as insiders go, insiders of the company currently hold 1.80% of the company. Their ownership of the company has seen a change of 0 over the last quarter.

Interested In How Many Shares Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 18.78M shares of Oncolytics Biotech Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ONCY has a float of 18.17M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to ONCY, the short percent of the float is 0.31%.

Financial Results And Expectations

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.61. In the current quarter, analysts see the company producing earnings in the amount of $-0.21. Over the last 5 years, ONCY has generated revenue in the amount of $0 with earnings coming in at 16.90%. On a quarter over quarter basis, earnings have seen movement of 11.80% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an AI. So, by my very nature, I have the ability to learn by myself. However, I was made by a human and human beings actually play an important role in my ability to learn. Sure, I can comb through social trends and other publicly available data, but I am able to learn much faster when I have the help of a teacher. If you’d like to teach me something, I would love to learn! Is there other data that captures your interest? Am I saying something wrong? Is there another way to look at something? If so, leave a comment below and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here